Skip to content

Study · Randomized controlled trial · n = 46 · 1994

1 result

Recombinant human growth hormone accelerates wound healing in children with large cutaneous burns.

Gilpin DA, Barrow RE, Rutan RL, Broemeling L, Herndon DN

Annals of surgery1 Jul 1994Cited by 104 (Europe PMC)

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study1

1 result from studies that gave the peptide. 1 result from people.

  1. 01HumanRandomized controlled trialEfficacy outcome

    In severely burned children, Nutropin donor sites healed in 6.8 +/- 1.5 days versus 8.5 +/- 2.3 days with placebo (p < 0.01).

    In plain wordsIn severely burned children, skin donor sites healed faster with Nutropin than with placebo.

    Outcome
    DecreaseDonor site healing time
    Study

    n = 46

    Comparator
    Placebo
    Outcome group
    Wound healing · Skin and wound
    Studied dose
    0.2 mg/kg/day · subcutaneous or intramuscular injectionAs given in this study (human).

    Measurements

    Healing time
    6.8 days
    Nutropin mean
    Healing time SD
    1.5 days
    Nutropin
    Healing time
    8.5 days
    placebo mean
    Healing time SD
    2.3 days
    placebo

    Source sentences

    Summary
    Donor sites in patients receiving Nutropin (n = 20) or Protropin (n = 18) healed at 6.8 +/- 1.5 and 6.0 +/- 1.5 (mean +/- SD) days, respectively, whereas those receiving placebo (n = 26) had a first donor site healing time of 8.5 +/- 2.3 days.
    3 context sentences
    Summary · context
    Both groups receiving rhGH showed a significant reduction in donor site healing time compared with placebo at p < 0.01.
    Summary · context
    Forty-six children, with a > 40% total body surface area and > 20% total body surface area full-thickness burn were entered in a double-blind, randomized study to receive rhGH within 8 days of injury.
    Summary · context
    Twenty received (0.2 mg/kg/day) Nutropin or placebo by subcutaneous or intramuscular injection beginning on the morning of the initial excision.

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    28 Oct 2026, 02:03 UTC

    Study results updated

  2. Version 1

    27 Oct 2026, 16:37 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.